Month: <span>April 2025</span>
Month: April 2025

Structural characterization of antibody-responses following Zolgensma treatment for AAV capsid engineering to expand patient cohorts

Nat Commun. 2025 Apr 19;16(1):3731. doi: 10.1038/s41467-025-59088-4. ABSTRACT Monoclonal antibodies are useful tools to dissect the neutralizing antibody response against the adeno-associated virus (AAV) capsids …

Social determinants of youth with mild intellectual disability in outpatient care for mental health disorders: a case-control study

Eur Child Adolesc Psychiatry. 2025 Apr 19. doi: 10.1007/s00787-025-02718-5. Online ahead of print. ABSTRACT This study examined the unique role of multiple social determinants of …

Pharmacokinetics and Safety of Ceftazidime-Avibactam in Neonates and Young Infants: a Phase 2a, Multicenter Prospective Trial

J Pediatric Infect Dis Soc. 2025 Apr 19:piaf028. doi: 10.1093/jpids/piaf028. Online ahead of print. ABSTRACT BACKGROUND: This phase 2a study evaluated pharmacokinetics and safety of …

Patterns of Use and Benefit of Triptans in the Treatment of Acute Headache Worsening in Youth With Post-Traumatic Headache

Pediatr Neurol. 2025 Mar 27;167:96-102. doi: 10.1016/j.pediatrneurol.2025.03.013. Online ahead of print. ABSTRACT BACKGROUND: Triptans are used to treat migraine attacks, but little to no evidence …